# A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)

> **NCT01386125** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 748 (actual)

## Conditions studied

- Nasal Polyps

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray (MFNS)
- **DRUG:** Placebo for MFNS

## Key facts

- **NCT ID:** NCT01386125
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 748 (ACTUAL)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386125, "A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01386125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*